|
1
|
Pleural effusion in a patient with multiple myeloma.
|
Clin Chem
|
2012
|
2.52
|
|
2
|
The small leucine-rich proteoglycan lumican inhibits melanoma progression.
|
Exp Cell Res
|
2004
|
1.18
|
|
3
|
Control of melanoma cell invasion by type IV collagen.
|
Cancer Detect Prev
|
2004
|
1.03
|
|
4
|
An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity. Implication in tumor invasion.
|
Crit Rev Oncol Hematol
|
2004
|
1.00
|
|
5
|
Control of melanoma progression by various matrikines from basement membrane macromolecules.
|
Crit Rev Oncol Hematol
|
2004
|
0.96
|
|
6
|
The YSNSG cyclopeptide derived from tumstatin inhibits tumor angiogenesis by down-regulating endothelial cell migration.
|
Int J Cancer
|
2010
|
0.95
|
|
7
|
In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model.
|
Exp Cell Res
|
2004
|
0.92
|
|
8
|
The antitumor properties of the alpha3(IV)-(185-203) peptide from the NC1 domain of type IV collagen (tumstatin) are conformation-dependent.
|
J Biol Chem
|
2003
|
0.87
|
|
9
|
Tetrastatin, the NC1 domain of the α4(IV) collagen chain: a novel potent anti-tumor matrikine.
|
PLoS One
|
2012
|
0.85
|
|
10
|
Structural and antitumor properties of the YSNSG cyclopeptide derived from tumstatin.
|
Chem Biol
|
2006
|
0.81
|
|
11
|
Lumcorin: a leucine-rich repeat 9-derived peptide from human lumican inhibiting melanoma cell migration.
|
FEBS Lett
|
2009
|
0.78
|
|
12
|
The NC1 domain of type XIX collagen inhibits melanoma cell migration.
|
Eur J Dermatol
|
2010
|
0.77
|
|
13
|
A new anti-tumor strategy based on in vivo tumstatin overexpression after plasmid electrotransfer in muscle.
|
Biochem Biophys Res Commun
|
2013
|
0.77
|
|
14
|
[Recommendations for the management of monoclonal gammopathies in biochemistry].
|
Ann Biol Clin (Paris)
|
2012
|
0.75
|
|
15
|
[Increased plasma C-reactive protein in a pregnant woman with multiple sclerosis: corticotherapy or not ?].
|
Ann Biol Clin (Paris)
|
2010
|
0.75
|
|
16
|
[Matrikines: a new anticancer therapeutic strategy].
|
Biol Aujourdhui
|
2012
|
0.75
|
|
17
|
Interference of M-paraprotein in automated urea assays.
|
Clin Chem Lab Med
|
2013
|
0.75
|
|
18
|
[Biological effects of collagen I and IV peptides].
|
J Soc Biol
|
2003
|
0.75
|
|
19
|
[Hyperamylasemia after cardiac surgery: which significance?].
|
Ann Biol Clin (Paris)
|
2011
|
0.75
|
|
20
|
Serum folate and vitamin B12: does light really matter?
|
Clin Chem Lab Med
|
2014
|
0.75
|